Share

March 11, 2014; 82 (10) Article

PRECREST: A phase II prevention and biomarker trial of creatine in at-risk Huntington disease

Herminia D. Rosas, Gheorghe Doros, Sona Gevorkian, Keith Malarick, Martin Reuter, Jean-Philippe Coutu, Tyler D. Triggs, Paul J. Wilkens, Wayne Matson, David H. Salat, Steven M. Hersch
First published February 7, 2014, DOI: https://doi.org/10.1212/WNL.0000000000000187
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
739

Share

Article Information

vol. 82 no. 10 850-857
DOI: 
https://doi.org/10.1212/WNL.0000000000000187
PubMed: 
24510496
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
0028-3878
Online ISSN: 
1526-632X
History: 
  • Received June 14, 2013
  • Accepted in final form November 19, 2013
  • First Published February 7, 2014.

Article Versions

Copyright & Usage: 
© 2014 American Academy of Neurology

Author Disclosures

    1. Herminia D. Rosas, MD,
    2. Gheorghe Doros, PhD,
    3. Sona Gevorkian, MSc,
    4. Keith Malarick, BS,
    5. Martin Reuter, PhD,
    6. Jean-Philippe Coutu, BS,
    7. Tyler D. Triggs, BS,
    8. Paul J. Wilkens, BS,
    9. Wayne Matson, PhD,
    10. David H. Salat, PhD and
    11. Steven M. Hersch, MD, PhD
  1. Herminia D. Rosas, MD,
    2. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NIH NINDS P01 NS058793 NIH, NINDS R01 NS042861

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  2. Gheorghe Doros, PhD,
    3. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  3. Sona Gevorkian, MSc,
    4. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NIH/NCCAM, Grant#5U01000613, Project Manager, 2010-2013

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  4. Keith Malarick, BS,
    5. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  5. Martin Reuter, PhD,
    6. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. Frontiers in Brain Imaging Methods (editorial borad, 2013)

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NIH/NIBIB 5R01EB006758-05 , 2012-2013, Investigator NIH/NCRR 8-P41-EB015896-14, 2012-2013, Investigator NIH/NICHD R01-HD071664-02, 2012-2013, Investigator NIH/NINDS 2-R01-NS042861-06A1, 2012-2013, Investigator NIH/NINDS 5-P01-NS058793-03, 2011-2013, Investigator NIH/NINDS 5R01NS052585-05,2011-2013, Investigator

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. Siemens, 2010-2013

    Legal Proceedings:

    1. NONE

  6. Jean-Philippe Coutu, BS,
    7. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. Biogen

    Research Support, Government Entities:

    1. NIH, R01NR010827, student, 2012

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  7. Tyler D. Triggs, BS,
    8. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  8. Paul J. Wilkens, BS,
    9. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  9. Wayne Matson, PhD,
    10. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. 1. (1) gut microbiome molecules as risk factors (2)novel diagnostics for peripheral gut microbiome levels 2. (1)use of metabolic mapping for secondary therapies (2)mathematical technique for discrimination by correlation 3. (1)covalently bound molecules as biomarkers (2)analytical technique for assessing epigenetic factors

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. (1)counterpoint health solutions inc., chief scientist,0.16 years.

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. (1)prana pharmaceuticals/contract

    Research Support, Government Entities:

    1. (1)Wylie Laboratories/NASA contract (2)University of Oslo/Norwegian government/contract (3)Mass General Hospital/NIH/sub contract

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. counterpoint health solutions inc.,0.16 years

    Legal Proceedings:

    1. NONE

  10. David H. Salat, PhD and
    11. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. Janssen Pharmaceuticals

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. Biogen Idec

    Research Support, Government Entities:

    1. NIHNS042861; NIHRRP4114075; NIHR21026104; NIHAG026484; NIHAG028676; R01NR010827;

    Research Support, Academic Entities:

    1. Executive Committee on Research (MGH)

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  11. Steven M. Hersch, MD, PhD
    12. Scientific Advisory Boards:

    1. 1) Pfizer, DSMB

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. Journal of Huntington's disease, editorial Board 2012- uncompensated.

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. 1) Azevan Pharmaceuticals

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. PRANA Biotechnology

    Research Support, Government Entities:

    1. NIH P01-NS058793....PI NIH U02-AT000613....PI NIH O1NS042861.....investigator NIH UO1-NS071789.....PI

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  1. From the Departments of Neurology (H.D.R., S.G., K.M., M.R., T.D.T., P.J.W., S.M.H.), Center for Neuro-imaging of Aging and Neurodegenerative Diseases (H.D.R., S.G., K.M., M.R., J.-P.C., T.D.T., P.J.W., D.H.S.), Athinoula A. Martinos Center for Biomedical Imaging (H.D.R., S.G., K.M., M.R., T.D.T., P.J.W., D.H.S.), and Radiology (H.D.R., M.R.), Massachusetts General Hospital and Harvard Medical School, Boston; Department of Biostatistics (G.D.), School of Public Health, Boston University, Boston; Harvard-MIT Division of Health Sciences and Technology (J.-P.C.), Cambridge; and Geriatric Research Education Clinical Center (W.M.), New England Veterans Administration, Bedford, MA.
  1. Correspondence to Dr. Rosas: rosas{at}helix.mgh.harvard.edu
View Full Text

Article usage

Article usage: February 2014 to February 2020

AbstractFullPdfSource
Feb 20141162172Highwire
Mar 2014175315298Highwire
Apr 20143445733Highwire
May 20141983715Highwire
Jun 20141262511Highwire
Jul 2014115156Highwire
Aug 2014583318Highwire
Sep 2014762915Highwire
Oct 2014822713Highwire
Nov 20147383Highwire
Dec 201468105Highwire
Jan 2015145910Highwire
Feb 201557167Highwire
Mar 20155987Highwire
Mar 201501412pmc
Apr 20156473Highwire
Apr 201502412pmc
May 20152321Highwire
May 201501910pmc
Jun 20154012Highwire
Jun 201502117pmc
Jul 20154143Highwire
Jul 20150168pmc
Aug 20155273Highwire
Aug 201501610pmc
Sep 20156277Highwire
Sep 201502818pmc
Oct 20152772Highwire
Oct 201502313pmc
Nov 20156545Highwire
Nov 201502213pmc
Dec 20155352Highwire
Dec 20150151pmc
Jan 20164342Highwire
Jan 20160216pmc
Feb 20164231Highwire
Feb 20160182pmc
Mar 20163762Highwire
Mar 20160198pmc
Apr 20161621Highwire
Apr 20160156pmc
May 20163011Highwire
May 20160133pmc
Jun 20163800Highwire
Jun 20160217pmc
Jul 20163522Highwire
Jul 20160176pmc
Aug 20162941Highwire
Aug 20160105pmc
Sep 20163851Highwire
Sep 20160134pmc
Oct 20163110Highwire
Oct 20160152pmc
Nov 20163001Highwire
Nov 20160177pmc
Dec 20162200Highwire
Dec 20160102pmc
Jan 20173900Highwire
Jan 20170111pmc
Feb 20175101Highwire
Feb 20170137pmc
Mar 20173210Highwire
Mar 20170177pmc
Apr 20173655Highwire
Apr 201771821pmc
May 20172800Highwire
May 201741111pmc
Jun 20171700Highwire
Jun 20174810pmc
Jul 20171930Highwire
Jul 201761012pmc
Aug 20171801Highwire
Aug 201731110pmc
Sep 20172600Highwire
Sep 20172910pmc
Oct 20172633Highwire
Oct 201772023pmc
Nov 20172121Highwire
Nov 201791818pmc
Dec 20171401Highwire
Jan 20182012Highwire
Feb 20184264Highwire
Mar 20186242Highwire
Apr 20185421Highwire
Apr 2018397pmc
May 20183522Highwire
Jun 20182710Highwire
Jun 2018255pmc
Jul 20183301Highwire
Aug 20182401Highwire
Aug 201841220pmc
Sep 20181300Highwire
Oct 20182312Highwire
Nov 20183245Highwire
Dec 20183542Highwire
Jan 2019651Highwire
Feb 20195332Highwire
Mar 20195010Highwire
Apr 20193513Highwire
May 20193200Highwire
Jun 2019601Highwire
Jul 20191110Highwire
Aug 20191713Highwire
Sep 20192213Highwire
Oct 20192200Highwire
Nov 20193711Highwire
Dec 20192331Highwire
Jan 20202721Highwire
Feb 20201912Highwire

Cited By...

Disputes & Debates: Rapid online correspondence

No comments have been published for this article.
Comment

NOTE: All authors' disclosures must be entered and current in our database before comments can be posted. Enter and update disclosures at http://submit.neurology.org. Exception: replies to comments concerning an article you originally authored do not require updated disclosures.

  • Stay timely. Submit only on articles published within the last 8 weeks.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • 200 words maximum.
  • 5 references maximum. Reference 1 must be the article on which you are commenting.
  • 5 authors maximum. Exception: replies can include all original authors of the article.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Disputes & Debates Submission Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

More Online

CME Course

Related Articles

Topics Discussed

Alert Me